Mylan To Pay $335 Million To Multiple States To Settle Opioid Claims
Mylan Inc. on April 7 agreed to pay up to $335 million in a multistate settlement agreement to end claims that the pharmaceutical company contributed to the opioid epidemic by manufacturing...To view the full article, register now.
Already a subscriber? Click here to view full article